CSNpharm
GM6001 is a broad spectrum MMPs inhibitor for MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MMP-14, and MMP-26 with Ki of 0.4 nM, 0.5 nM, 27 nM, 3.7 nM, 0.1 nM, 0.2 nM, 3.6 nM, 13.4 nM, 0.36 nM, respectively.
More Information
Supplier Page
CSNpharm
GMB-475 is a degrader of BCR-ABL1 tyrosine kinase based on PROTAC, overcoming BCR-ABL1-dependent drug resistance. GMB-475 reduced viability and increased apoptosis in primary CML CD34+ cells, with no effect on healthy CD34+ cells at identical concentrations.
More Information
Supplier Page
CSNpharm
GMB-475 is a degrader of BCR-ABL1 tyrosine kinase based on PROTAC, overcoming BCR-ABL1-dependent drug resistance. GMB-475 reduced viability and increased apoptosis in primary CML CD34+ cells, with no effect on healthy CD34+ cells at identical concentrations.
More Information
Supplier Page
CSNpharm
GMB-475 is a degrader of BCR-ABL1 tyrosine kinase based on PROTAC, overcoming BCR-ABL1-dependent drug resistance. GMB-475 reduced viability and increased apoptosis in primary CML CD34+ cells, with no effect on healthy CD34+ cells at identical concentrations.
More Information
Supplier Page
CSNpharm
GMB-475 is a degrader of BCR-ABL1 tyrosine kinase based on PROTAC, overcoming BCR-ABL1-dependent drug resistance. GMB-475 reduced viability and increased apoptosis in primary CML CD34+ cells, with no effect on healthy CD34+ cells at identical concentrations.
More Information
Supplier Page
CSNpharm
GMB-475 is a degrader of BCR-ABL1 tyrosine kinase based on PROTAC, overcoming BCR-ABL1-dependent drug resistance. GMB-475 reduced viability and increased apoptosis in primary CML CD34+ cells, with no effect on healthy CD34+ cells at identical concentrations.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Gnetol
100mg
| ≥95%
CSNpharm
CSNpharm
CSNpharm
Go6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively and less potent to PKCζ and inactive to PKCμ.
More Information
Supplier Page
CSNpharm
Go6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively and less potent to PKCζ and inactive to PKCμ.
More Information
Supplier Page
CSNpharm
Go6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively and less potent to PKCζ and inactive to PKCμ.
More Information
Supplier Page
Go6983
100mg
| ≥99%
CSNpharm
Go6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively and less potent to PKCζ and inactive to PKCμ.
More Information
Supplier Page
CSNpharm
Gomisin A is a major dibenzocyclooctadiene lignan from medicinal plant Schizandra Chinese, exhibiting hepatoprotective, antiviral, anticancer, neuroprotective and anti-inflammatory activity.
More Information
Supplier Page
CSNpharm
Gomisin A is a major dibenzocyclooctadiene lignan from medicinal plant Schizandra Chinese, exhibiting hepatoprotective, antiviral, anticancer, neuroprotective and anti-inflammatory activity.
More Information
Supplier Page
CSNpharm
Gomisin A is a major dibenzocyclooctadiene lignan from medicinal plant Schizandra Chinese, exhibiting hepatoprotective, antiviral, anticancer, neuroprotective and anti-inflammatory activity.
More Information
Supplier Page
CSNpharm
Gomisin J is a natural product isolated and purified from the fruits of Schizandra chinensis with vasodilatory activity that mediates mainly by calcium-dependent activation of eNOS with subsequent production of endothelial NO, and inhibits LPO in rat liver mitochondria and protects cultured myocardial cells from being injured by calcium paradox.
More Information
Supplier Page
CSNpharm
Gomisin N, a natural product isolated and purified from the fruits of Schizandra chinensis with anti-hepatotoxic, anticancer, anti-oxidative and anti-inflammatory activities.
More Information
Supplier Page
CSNpharm
Gomisin N, a natural product isolated and purified from the fruits of Schizandra chinensis with anti-hepatotoxic, anticancer, anti-oxidative and anti-inflammatory activities.
More Information
Supplier Page
CSNpharm
Goniothalamin, a natural product isolated and purified from the herbs of Goniothalamus griffithii, enhances rather than inhibits the ATPase activity of a cyanobacterial Hsp90 (HtpG) and a yeast Hsp90, increases both K(m) and k(cat) of the Hsp90s.
More Information
Supplier Page
CSNpharm
Goniothalamin, a natural product isolated and purified from the herbs of Goniothalamus griffithii, enhances rather than inhibits the ATPase activity of a cyanobacterial Hsp90 (HtpG) and a yeast Hsp90, increases both K(m) and k(cat) of the Hsp90s.
More Information
Supplier Page
CSNpharm
Gossypol has been known to exert a potential for anti-cancer, anti-inflammatory and other important therapeutic activities, gossypol binds and antagonizes anti-apoptotic effect of Bcl-2 family proteins
More Information
Supplier Page
CSNpharm
Gossypol has been known to exert a potential for anti-cancer, anti-inflammatory and other important therapeutic activities, gossypol binds and antagonizes anti-apoptotic effect of Bcl-2 family proteins
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
GPDA
25mg
| ≥98%
CSNpharm
GPDA
100mg
| ≥98%
CSNpharm
GPDA
50mg
| ≥98%
CSNpharm
GPDA
10mg
| ≥98%
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
GR148672X is a triacyglycerol hydrolase (TGH) inhibitor with an IC50 of 4 nM extracted from patent WO 2001016358 A2.
More Information
Supplier Page
CSNpharm
GR148672X is a triacyglycerol hydrolase (TGH) inhibitor with an IC50 of 4 nM extracted from patent WO 2001016358 A2.
More Information
Supplier Page
CSNpharm
GR148672X is a triacyglycerol hydrolase (TGH) inhibitor with an IC50 of 4 nM extracted from patent WO 2001016358 A2.
More Information
Supplier Page